This inventor holds 69 USPTO granted patents and 23 published patent applications, plus 9 CIPO patents and 29 EPO patents, primarily in Muscarinic Receptor Agonists (CPC class C07D). Top assignees: Heptares Therapeutics Limited, Nxera Pharma UK Limited, Astrazeneca Ab (Publ). Active years: 2010-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Hertfordshire, GB (2015 - 2016)
- Welwyn Garden City, GB (2017 - 2019)
- Welwyn Garden, GB (2017 - 2019)
- Cambridge, GB (2010 - 2024)
Company Filing History:
50 out of 85 
14 out of 18 
2 out of 2 Years Active: 2010-2026
Areas of Expertise:
Title: The Innovative Contributions of Giles Albert Brown
Introduction
Giles Albert Brown is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, holding a remarkable 69 patents. His work focuses on developing novel compounds that target specific receptors for the treatment of various diseases.
Latest Patents
Among his latest patents are the Morpholine-3-carboxamide derivatives, which serve as prostaglandin E2 receptor 4 (EP4) agonists. These compounds are designed for the treatment of gastrointestinal and pulmonary diseases. The disclosures detail novel compounds of formula I and their use in managing disorders associated with EP receptors. Another notable patent involves GLP-1 receptor antagonists, which are aimed at treating disorders related to Glucagon-like peptide-1 (GLP-1) receptors. The disclosures for these compounds also include specific formulas and their therapeutic applications.
Career Highlights
Giles has worked with several notable companies in the pharmaceutical industry, including Heptares Therapeutics Limited and Nxera Pharma UK Limited. His experience in these organizations has allowed him to contribute to groundbreaking research and development in drug discovery.
Collaborations
Throughout his career, Giles has collaborated with esteemed colleagues such as Miles Stuart Congreve and Benjamin Gerald Tehan. These partnerships have fostered innovation and have been instrumental in advancing their shared research goals.
Conclusion
Giles Albert Brown's contributions to the field of pharmaceuticals through his numerous patents and collaborations highlight his role as a leading inventor. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile